Email this article 
INTERVENTIONAL STRATEGY FOR CLINICALLY SIGNIFICANT THROMBOSIS OF THE SUPERIOR VENA CAVA AND BRACHIOCEPHALIC VEIN
- Authors: Vasiliev AE1, Margolin OV1, Karagyulyan SR1, Rogov DA1, Gitelzon DG1, Vasiliev MA2, Gitelzon EA2
-
Affiliations:
- FGBU Research Center for Hematology, Moscow, Russia
- RUDN University, Moscow, Russia
- Issue: Vol 21, No 2 (2017)
- Pages: 312-315
- Section: Articles
- URL: https://journals.rudn.ru/medicine/article/view/16652
- DOI: https://doi.org/10.22363/2313-0245-2017-21-2-312-315
Cite item
Full Text
Abstract
Superior vena cava syndrome (SVCS) is a relatively common complication of malignant mediastinal tumors and can cause severe functional impairment. Over the past 20 years, in addition to the conventional management of the disease, interventional treatment of this syndrome has become a viable option for alleviating the symptoms of SVCS. Thus, multidisciplinary care can maximize the effectiveness of treatment for patients with SVCS.
About the authors
A E Vasiliev
FGBU Research Center for Hematology, Moscow, Russia
Author for correspondence.
Email: atnlu88@mail.ru
O V Margolin
FGBU Research Center for Hematology, Moscow, Russia
Email: konovalov_oe@rudn.university
S R Karagyulyan
FGBU Research Center for Hematology, Moscow, Russia
Email: konovalov_oe@rudn.university
D A Rogov
FGBU Research Center for Hematology, Moscow, Russia
Email: konovalov_oe@rudn.university
D G Gitelzon
FGBU Research Center for Hematology, Moscow, Russia
Email: konovalov_oe@rudn.university
M A Vasiliev
RUDN University, Moscow, Russia
Email: konovalov_oe@rudn.university
E A Gitelzon
RUDN University, Moscow, Russia
Email: konovalov_oe@rudn.university
References
- Hunter W. & Johnston W. The history of an aneurysm of the aorta, with some remarks on aneu-rysms in general. London: William Johnston; 1757.
- Christopher Straka, James Ying, Feng-Ming Kong, Christopher D. Willey, Joseph Kaminski, & D.W. Nathan Kim. Review of evolving etiologies, implications and treatment strategies for the su-perior vena cava syndrome. Springerplus. 2016; 5: 229.
- Mohammed S. Al-Natour, Pouya Entezami, Munier M.S. Nazzal, Casabianca A.B., Ragheb As-saly, Kalen Riley & Daniel Gaudin. Superior vena cava syndrome with retropharyngeal edema as a complication of ventriculoatrial shunt. Clinical Case Reports. 2015; 3(10): 777—780.
- Schechter M.M. The superior vena cava syndrome. Am. J. Med. Sci. 1954. 227:46—56.
- Flounders J. Superior vena cava syndrome. Oncol Nurs Forum. 2003. 30(4):E84—8.
- Hassikou H. Bono W., Bahiri R. et al. Vascularinvolvement in Behcet’s disease. Two case reports. Joint bone spine. 2002 June. 69(4):416—8.
- Rice T.W., Rodriguez R.M., Light R.W. The superior vena cava syndrome: clinical characteristics and evolving etiology. Medicine (Baltimore). 2006 Jan; 85(1):37—42.
- Marcy P.Y., Magne N., Bentolila F., et al. Superior vena cava obstruction: is stenting necessary? Support Care Cancer. 2001 Mar. 9(2):103—7.
- Akoglu H., Yilmaz R., Peynircioglu B., et al. A rare complicationof hemodialysis catheters: supe-rior vena cava syndrome. Hemodial Int. 2007 Oct.11(4):385—91.
- Wan J.F., Bezjak A. Superior vena cava syndrome. Hematol Oncol Clin North Am. 2010 Jun; 24(3):501—13.
